Medical Care
Global NCI Digital Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 78718
- Pages: 82
- Figures: 85
- Views: 24
The global market for NCI Digital Therapeutics was valued at US$ 929 million in the year 2024 and is projected to reach a revised size of US$ 1862 million by 2031, growing at a CAGR of 10.5% during the forecast period.
NCI digital therapeutics refer to an innovative treatment approach for cognitive impairments caused by neurodegenerative diseases, particularly for Alzheimer's disease patients. Utilizing digital technologies such as virtual reality and artificial intelligence, it provides personalized cognitive rehabilitation training to enhance the quality of life for these patients. The necessity of NCI digital therapeutics lies in its ability to complement the shortcomings of traditional treatment methods, offering a more flexible and efficient rehabilitation solution. Its characteristic is the use of technological means to achieve precise treatment, focusing on individual differences and tailoring the therapy to each patient. The superiority of NCI digital therapeutic is reflected in its ability to overcome geographical barriers, reduce treatment costs, and increase patient engagement and therapeutic outcomes, bringing a new rehabilitation experience to Alzheimer's disease patients
North American market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for NCI Digital Therapeutics in Medical Rehab Center is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of NCI Digital Therapeutics include MindMaze Labs, Akili, Cognoa, GrayMatters Health, Otsuka Pharmaceutical, TALi Health, Dario Health, Better Therapeutics, Nanjing Vishee Medical Technology, Zhejiang BrainAurora Medical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NCI Digital Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NCI Digital Therapeutics.
The NCI Digital Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NCI Digital Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NCI Digital Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MindMaze Labs
Akili
Cognoa
GrayMatters Health
Otsuka Pharmaceutical
TALi Health
Dario Health
Better Therapeutics
Nanjing Vishee Medical Technology
Zhejiang BrainAurora Medical Technology
Hunan Mental Health Medicine Technology
Hunan Aize Medical Technology
Qingdao Zhisong Technology
Segment by Type
AD
AMCI
Segment by Application
Medical Rehab Center
Hospitals
Geriatric Facilities
Nursing Homes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NCI Digital Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
NCI digital therapeutics refer to an innovative treatment approach for cognitive impairments caused by neurodegenerative diseases, particularly for Alzheimer's disease patients. Utilizing digital technologies such as virtual reality and artificial intelligence, it provides personalized cognitive rehabilitation training to enhance the quality of life for these patients. The necessity of NCI digital therapeutics lies in its ability to complement the shortcomings of traditional treatment methods, offering a more flexible and efficient rehabilitation solution. Its characteristic is the use of technological means to achieve precise treatment, focusing on individual differences and tailoring the therapy to each patient. The superiority of NCI digital therapeutic is reflected in its ability to overcome geographical barriers, reduce treatment costs, and increase patient engagement and therapeutic outcomes, bringing a new rehabilitation experience to Alzheimer's disease patients
North American market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for NCI Digital Therapeutics in Medical Rehab Center is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of NCI Digital Therapeutics include MindMaze Labs, Akili, Cognoa, GrayMatters Health, Otsuka Pharmaceutical, TALi Health, Dario Health, Better Therapeutics, Nanjing Vishee Medical Technology, Zhejiang BrainAurora Medical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NCI Digital Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NCI Digital Therapeutics.
The NCI Digital Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NCI Digital Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NCI Digital Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MindMaze Labs
Akili
Cognoa
GrayMatters Health
Otsuka Pharmaceutical
TALi Health
Dario Health
Better Therapeutics
Nanjing Vishee Medical Technology
Zhejiang BrainAurora Medical Technology
Hunan Mental Health Medicine Technology
Hunan Aize Medical Technology
Qingdao Zhisong Technology
Segment by Type
AD
AMCI
Segment by Application
Medical Rehab Center
Hospitals
Geriatric Facilities
Nursing Homes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NCI Digital Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NCI Digital Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AD
1.2.3 AMCI
1.3 Market by Application
1.3.1 Global NCI Digital Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Rehab Center
1.3.3 Hospitals
1.3.4 Geriatric Facilities
1.3.5 Nursing Homes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NCI Digital Therapeutics Market Perspective (2020-2031)
2.2 Global NCI Digital Therapeutics Growth Trends by Region
2.2.1 Global NCI Digital Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NCI Digital Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 NCI Digital Therapeutics Market Dynamics
2.3.1 NCI Digital Therapeutics Industry Trends
2.3.2 NCI Digital Therapeutics Market Drivers
2.3.3 NCI Digital Therapeutics Market Challenges
2.3.4 NCI Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NCI Digital Therapeutics Players by Revenue
3.1.1 Global Top NCI Digital Therapeutics Players by Revenue (2020-2025)
3.1.2 Global NCI Digital Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Top NCI Digital Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NCI Digital Therapeutics Revenue
3.4 Global NCI Digital Therapeutics Market Concentration Ratio
3.4.1 Global NCI Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NCI Digital Therapeutics Revenue in 2024
3.5 Global Key Players of NCI Digital Therapeutics Head office and Area Served
3.6 Global Key Players of NCI Digital Therapeutics, Product and Application
3.7 Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NCI Digital Therapeutics Breakdown Data by Type
4.1 Global NCI Digital Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031)
5 NCI Digital Therapeutics Breakdown Data by Application
5.1 Global NCI Digital Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NCI Digital Therapeutics Market Size (2020-2031)
6.2 North America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NCI Digital Therapeutics Market Size by Country (2020-2025)
6.4 North America NCI Digital Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NCI Digital Therapeutics Market Size (2020-2031)
7.2 Europe NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NCI Digital Therapeutics Market Size by Country (2020-2025)
7.4 Europe NCI Digital Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NCI Digital Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific NCI Digital Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NCI Digital Therapeutics Market Size (2020-2031)
9.2 Latin America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NCI Digital Therapeutics Market Size by Country (2020-2025)
9.4 Latin America NCI Digital Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NCI Digital Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MindMaze Labs
11.1.1 MindMaze Labs Company Details
11.1.2 MindMaze Labs Business Overview
11.1.3 MindMaze Labs NCI Digital Therapeutics Introduction
11.1.4 MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025)
11.1.5 MindMaze Labs Recent Development
11.2 Akili
11.2.1 Akili Company Details
11.2.2 Akili Business Overview
11.2.3 Akili NCI Digital Therapeutics Introduction
11.2.4 Akili Revenue in NCI Digital Therapeutics Business (2020-2025)
11.2.5 Akili Recent Development
11.3 Cognoa
11.3.1 Cognoa Company Details
11.3.2 Cognoa Business Overview
11.3.3 Cognoa NCI Digital Therapeutics Introduction
11.3.4 Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025)
11.3.5 Cognoa Recent Development
11.4 GrayMatters Health
11.4.1 GrayMatters Health Company Details
11.4.2 GrayMatters Health Business Overview
11.4.3 GrayMatters Health NCI Digital Therapeutics Introduction
11.4.4 GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.4.5 GrayMatters Health Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical NCI Digital Therapeutics Introduction
11.5.4 Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 TALi Health
11.6.1 TALi Health Company Details
11.6.2 TALi Health Business Overview
11.6.3 TALi Health NCI Digital Therapeutics Introduction
11.6.4 TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.6.5 TALi Health Recent Development
11.7 Dario Health
11.7.1 Dario Health Company Details
11.7.2 Dario Health Business Overview
11.7.3 Dario Health NCI Digital Therapeutics Introduction
11.7.4 Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.7.5 Dario Health Recent Development
11.8 Better Therapeutics
11.8.1 Better Therapeutics Company Details
11.8.2 Better Therapeutics Business Overview
11.8.3 Better Therapeutics NCI Digital Therapeutics Introduction
11.8.4 Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025)
11.8.5 Better Therapeutics Recent Development
11.9 Nanjing Vishee Medical Technology
11.9.1 Nanjing Vishee Medical Technology Company Details
11.9.2 Nanjing Vishee Medical Technology Business Overview
11.9.3 Nanjing Vishee Medical Technology NCI Digital Therapeutics Introduction
11.9.4 Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.9.5 Nanjing Vishee Medical Technology Recent Development
11.10 Zhejiang BrainAurora Medical Technology
11.10.1 Zhejiang BrainAurora Medical Technology Company Details
11.10.2 Zhejiang BrainAurora Medical Technology Business Overview
11.10.3 Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Introduction
11.10.4 Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.10.5 Zhejiang BrainAurora Medical Technology Recent Development
11.11 Hunan Mental Health Medicine Technology
11.11.1 Hunan Mental Health Medicine Technology Company Details
11.11.2 Hunan Mental Health Medicine Technology Business Overview
11.11.3 Hunan Mental Health Medicine Technology NCI Digital Therapeutics Introduction
11.11.4 Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.11.5 Hunan Mental Health Medicine Technology Recent Development
11.12 Hunan Aize Medical Technology
11.12.1 Hunan Aize Medical Technology Company Details
11.12.2 Hunan Aize Medical Technology Business Overview
11.12.3 Hunan Aize Medical Technology NCI Digital Therapeutics Introduction
11.12.4 Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.12.5 Hunan Aize Medical Technology Recent Development
11.13 Qingdao Zhisong Technology
11.13.1 Qingdao Zhisong Technology Company Details
11.13.2 Qingdao Zhisong Technology Business Overview
11.13.3 Qingdao Zhisong Technology NCI Digital Therapeutics Introduction
11.13.4 Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.13.5 Qingdao Zhisong Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NCI Digital Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AD
1.2.3 AMCI
1.3 Market by Application
1.3.1 Global NCI Digital Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Rehab Center
1.3.3 Hospitals
1.3.4 Geriatric Facilities
1.3.5 Nursing Homes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NCI Digital Therapeutics Market Perspective (2020-2031)
2.2 Global NCI Digital Therapeutics Growth Trends by Region
2.2.1 Global NCI Digital Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NCI Digital Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 NCI Digital Therapeutics Market Dynamics
2.3.1 NCI Digital Therapeutics Industry Trends
2.3.2 NCI Digital Therapeutics Market Drivers
2.3.3 NCI Digital Therapeutics Market Challenges
2.3.4 NCI Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NCI Digital Therapeutics Players by Revenue
3.1.1 Global Top NCI Digital Therapeutics Players by Revenue (2020-2025)
3.1.2 Global NCI Digital Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Top NCI Digital Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NCI Digital Therapeutics Revenue
3.4 Global NCI Digital Therapeutics Market Concentration Ratio
3.4.1 Global NCI Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NCI Digital Therapeutics Revenue in 2024
3.5 Global Key Players of NCI Digital Therapeutics Head office and Area Served
3.6 Global Key Players of NCI Digital Therapeutics, Product and Application
3.7 Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NCI Digital Therapeutics Breakdown Data by Type
4.1 Global NCI Digital Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031)
5 NCI Digital Therapeutics Breakdown Data by Application
5.1 Global NCI Digital Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NCI Digital Therapeutics Market Size (2020-2031)
6.2 North America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NCI Digital Therapeutics Market Size by Country (2020-2025)
6.4 North America NCI Digital Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NCI Digital Therapeutics Market Size (2020-2031)
7.2 Europe NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NCI Digital Therapeutics Market Size by Country (2020-2025)
7.4 Europe NCI Digital Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NCI Digital Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific NCI Digital Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NCI Digital Therapeutics Market Size (2020-2031)
9.2 Latin America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NCI Digital Therapeutics Market Size by Country (2020-2025)
9.4 Latin America NCI Digital Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NCI Digital Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MindMaze Labs
11.1.1 MindMaze Labs Company Details
11.1.2 MindMaze Labs Business Overview
11.1.3 MindMaze Labs NCI Digital Therapeutics Introduction
11.1.4 MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025)
11.1.5 MindMaze Labs Recent Development
11.2 Akili
11.2.1 Akili Company Details
11.2.2 Akili Business Overview
11.2.3 Akili NCI Digital Therapeutics Introduction
11.2.4 Akili Revenue in NCI Digital Therapeutics Business (2020-2025)
11.2.5 Akili Recent Development
11.3 Cognoa
11.3.1 Cognoa Company Details
11.3.2 Cognoa Business Overview
11.3.3 Cognoa NCI Digital Therapeutics Introduction
11.3.4 Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025)
11.3.5 Cognoa Recent Development
11.4 GrayMatters Health
11.4.1 GrayMatters Health Company Details
11.4.2 GrayMatters Health Business Overview
11.4.3 GrayMatters Health NCI Digital Therapeutics Introduction
11.4.4 GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.4.5 GrayMatters Health Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical NCI Digital Therapeutics Introduction
11.5.4 Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 TALi Health
11.6.1 TALi Health Company Details
11.6.2 TALi Health Business Overview
11.6.3 TALi Health NCI Digital Therapeutics Introduction
11.6.4 TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.6.5 TALi Health Recent Development
11.7 Dario Health
11.7.1 Dario Health Company Details
11.7.2 Dario Health Business Overview
11.7.3 Dario Health NCI Digital Therapeutics Introduction
11.7.4 Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025)
11.7.5 Dario Health Recent Development
11.8 Better Therapeutics
11.8.1 Better Therapeutics Company Details
11.8.2 Better Therapeutics Business Overview
11.8.3 Better Therapeutics NCI Digital Therapeutics Introduction
11.8.4 Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025)
11.8.5 Better Therapeutics Recent Development
11.9 Nanjing Vishee Medical Technology
11.9.1 Nanjing Vishee Medical Technology Company Details
11.9.2 Nanjing Vishee Medical Technology Business Overview
11.9.3 Nanjing Vishee Medical Technology NCI Digital Therapeutics Introduction
11.9.4 Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.9.5 Nanjing Vishee Medical Technology Recent Development
11.10 Zhejiang BrainAurora Medical Technology
11.10.1 Zhejiang BrainAurora Medical Technology Company Details
11.10.2 Zhejiang BrainAurora Medical Technology Business Overview
11.10.3 Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Introduction
11.10.4 Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.10.5 Zhejiang BrainAurora Medical Technology Recent Development
11.11 Hunan Mental Health Medicine Technology
11.11.1 Hunan Mental Health Medicine Technology Company Details
11.11.2 Hunan Mental Health Medicine Technology Business Overview
11.11.3 Hunan Mental Health Medicine Technology NCI Digital Therapeutics Introduction
11.11.4 Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.11.5 Hunan Mental Health Medicine Technology Recent Development
11.12 Hunan Aize Medical Technology
11.12.1 Hunan Aize Medical Technology Company Details
11.12.2 Hunan Aize Medical Technology Business Overview
11.12.3 Hunan Aize Medical Technology NCI Digital Therapeutics Introduction
11.12.4 Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.12.5 Hunan Aize Medical Technology Recent Development
11.13 Qingdao Zhisong Technology
11.13.1 Qingdao Zhisong Technology Company Details
11.13.2 Qingdao Zhisong Technology Business Overview
11.13.3 Qingdao Zhisong Technology NCI Digital Therapeutics Introduction
11.13.4 Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025)
11.13.5 Qingdao Zhisong Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NCI Digital Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AD
Table 3. Key Players of AMCI
Table 4. Global NCI Digital Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NCI Digital Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NCI Digital Therapeutics Market Share by Region (2020-2025)
Table 8. Global NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NCI Digital Therapeutics Market Share by Region (2026-2031)
Table 10. NCI Digital Therapeutics Market Trends
Table 11. NCI Digital Therapeutics Market Drivers
Table 12. NCI Digital Therapeutics Market Challenges
Table 13. NCI Digital Therapeutics Market Restraints
Table 14. Global NCI Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NCI Digital Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top NCI Digital Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NCI Digital Therapeutics as of 2024)
Table 17. Ranking of Global Top NCI Digital Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NCI Digital Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NCI Digital Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of NCI Digital Therapeutics, Product and Application
Table 21. Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NCI Digital Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NCI Digital Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NCI Digital Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global NCI Digital Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NCI Digital Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NCI Digital Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NCI Digital Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. MindMaze Labs Company Details
Table 47. MindMaze Labs Business Overview
Table 48. MindMaze Labs NCI Digital Therapeutics Product
Table 49. MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 50. MindMaze Labs Recent Development
Table 51. Akili Company Details
Table 52. Akili Business Overview
Table 53. Akili NCI Digital Therapeutics Product
Table 54. Akili Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Akili Recent Development
Table 56. Cognoa Company Details
Table 57. Cognoa Business Overview
Table 58. Cognoa NCI Digital Therapeutics Product
Table 59. Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Cognoa Recent Development
Table 61. GrayMatters Health Company Details
Table 62. GrayMatters Health Business Overview
Table 63. GrayMatters Health NCI Digital Therapeutics Product
Table 64. GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 65. GrayMatters Health Recent Development
Table 66. Otsuka Pharmaceutical Company Details
Table 67. Otsuka Pharmaceutical Business Overview
Table 68. Otsuka Pharmaceutical NCI Digital Therapeutics Product
Table 69. Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Otsuka Pharmaceutical Recent Development
Table 71. TALi Health Company Details
Table 72. TALi Health Business Overview
Table 73. TALi Health NCI Digital Therapeutics Product
Table 74. TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 75. TALi Health Recent Development
Table 76. Dario Health Company Details
Table 77. Dario Health Business Overview
Table 78. Dario Health NCI Digital Therapeutics Product
Table 79. Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Dario Health Recent Development
Table 81. Better Therapeutics Company Details
Table 82. Better Therapeutics Business Overview
Table 83. Better Therapeutics NCI Digital Therapeutics Product
Table 84. Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Better Therapeutics Recent Development
Table 86. Nanjing Vishee Medical Technology Company Details
Table 87. Nanjing Vishee Medical Technology Business Overview
Table 88. Nanjing Vishee Medical Technology NCI Digital Therapeutics Product
Table 89. Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Nanjing Vishee Medical Technology Recent Development
Table 91. Zhejiang BrainAurora Medical Technology Company Details
Table 92. Zhejiang BrainAurora Medical Technology Business Overview
Table 93. Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Product
Table 94. Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Zhejiang BrainAurora Medical Technology Recent Development
Table 96. Hunan Mental Health Medicine Technology Company Details
Table 97. Hunan Mental Health Medicine Technology Business Overview
Table 98. Hunan Mental Health Medicine Technology NCI Digital Therapeutics Product
Table 99. Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Hunan Mental Health Medicine Technology Recent Development
Table 101. Hunan Aize Medical Technology Company Details
Table 102. Hunan Aize Medical Technology Business Overview
Table 103. Hunan Aize Medical Technology NCI Digital Therapeutics Product
Table 104. Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Hunan Aize Medical Technology Recent Development
Table 106. Qingdao Zhisong Technology Company Details
Table 107. Qingdao Zhisong Technology Business Overview
Table 108. Qingdao Zhisong Technology NCI Digital Therapeutics Product
Table 109. Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Qingdao Zhisong Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. NCI Digital Therapeutics Picture
Figure 2. Global NCI Digital Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NCI Digital Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. AD Features
Figure 5. AMCI Features
Figure 6. Global NCI Digital Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NCI Digital Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Medical Rehab Center Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Geriatric Facilities Case Studies
Figure 11. Nursing Homes Case Studies
Figure 12. Others Case Studies
Figure 13. NCI Digital Therapeutics Report Years Considered
Figure 14. Global NCI Digital Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global NCI Digital Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global NCI Digital Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global NCI Digital Therapeutics Market Share by Players in 2024
Figure 18. Global NCI Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by NCI Digital Therapeutics Revenue in 2024
Figure 20. North America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 22. United States NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NCI Digital Therapeutics Market Share by Region (2020-2031)
Figure 34. China NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. MindMaze Labs Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 50. Akili Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 51. Cognoa Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 52. GrayMatters Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 54. TALi Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 55. Dario Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 56. Better Therapeutics Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 57. Nanjing Vishee Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 58. Zhejiang BrainAurora Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 59. Hunan Mental Health Medicine Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 60. Hunan Aize Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 61. Qingdao Zhisong Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global NCI Digital Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AD
Table 3. Key Players of AMCI
Table 4. Global NCI Digital Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NCI Digital Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NCI Digital Therapeutics Market Share by Region (2020-2025)
Table 8. Global NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NCI Digital Therapeutics Market Share by Region (2026-2031)
Table 10. NCI Digital Therapeutics Market Trends
Table 11. NCI Digital Therapeutics Market Drivers
Table 12. NCI Digital Therapeutics Market Challenges
Table 13. NCI Digital Therapeutics Market Restraints
Table 14. Global NCI Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NCI Digital Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top NCI Digital Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NCI Digital Therapeutics as of 2024)
Table 17. Ranking of Global Top NCI Digital Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NCI Digital Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NCI Digital Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of NCI Digital Therapeutics, Product and Application
Table 21. Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NCI Digital Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NCI Digital Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NCI Digital Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global NCI Digital Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NCI Digital Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NCI Digital Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NCI Digital Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. MindMaze Labs Company Details
Table 47. MindMaze Labs Business Overview
Table 48. MindMaze Labs NCI Digital Therapeutics Product
Table 49. MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 50. MindMaze Labs Recent Development
Table 51. Akili Company Details
Table 52. Akili Business Overview
Table 53. Akili NCI Digital Therapeutics Product
Table 54. Akili Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Akili Recent Development
Table 56. Cognoa Company Details
Table 57. Cognoa Business Overview
Table 58. Cognoa NCI Digital Therapeutics Product
Table 59. Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Cognoa Recent Development
Table 61. GrayMatters Health Company Details
Table 62. GrayMatters Health Business Overview
Table 63. GrayMatters Health NCI Digital Therapeutics Product
Table 64. GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 65. GrayMatters Health Recent Development
Table 66. Otsuka Pharmaceutical Company Details
Table 67. Otsuka Pharmaceutical Business Overview
Table 68. Otsuka Pharmaceutical NCI Digital Therapeutics Product
Table 69. Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Otsuka Pharmaceutical Recent Development
Table 71. TALi Health Company Details
Table 72. TALi Health Business Overview
Table 73. TALi Health NCI Digital Therapeutics Product
Table 74. TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 75. TALi Health Recent Development
Table 76. Dario Health Company Details
Table 77. Dario Health Business Overview
Table 78. Dario Health NCI Digital Therapeutics Product
Table 79. Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Dario Health Recent Development
Table 81. Better Therapeutics Company Details
Table 82. Better Therapeutics Business Overview
Table 83. Better Therapeutics NCI Digital Therapeutics Product
Table 84. Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Better Therapeutics Recent Development
Table 86. Nanjing Vishee Medical Technology Company Details
Table 87. Nanjing Vishee Medical Technology Business Overview
Table 88. Nanjing Vishee Medical Technology NCI Digital Therapeutics Product
Table 89. Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Nanjing Vishee Medical Technology Recent Development
Table 91. Zhejiang BrainAurora Medical Technology Company Details
Table 92. Zhejiang BrainAurora Medical Technology Business Overview
Table 93. Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Product
Table 94. Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Zhejiang BrainAurora Medical Technology Recent Development
Table 96. Hunan Mental Health Medicine Technology Company Details
Table 97. Hunan Mental Health Medicine Technology Business Overview
Table 98. Hunan Mental Health Medicine Technology NCI Digital Therapeutics Product
Table 99. Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Hunan Mental Health Medicine Technology Recent Development
Table 101. Hunan Aize Medical Technology Company Details
Table 102. Hunan Aize Medical Technology Business Overview
Table 103. Hunan Aize Medical Technology NCI Digital Therapeutics Product
Table 104. Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Hunan Aize Medical Technology Recent Development
Table 106. Qingdao Zhisong Technology Company Details
Table 107. Qingdao Zhisong Technology Business Overview
Table 108. Qingdao Zhisong Technology NCI Digital Therapeutics Product
Table 109. Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Qingdao Zhisong Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. NCI Digital Therapeutics Picture
Figure 2. Global NCI Digital Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NCI Digital Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. AD Features
Figure 5. AMCI Features
Figure 6. Global NCI Digital Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NCI Digital Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Medical Rehab Center Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Geriatric Facilities Case Studies
Figure 11. Nursing Homes Case Studies
Figure 12. Others Case Studies
Figure 13. NCI Digital Therapeutics Report Years Considered
Figure 14. Global NCI Digital Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global NCI Digital Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global NCI Digital Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global NCI Digital Therapeutics Market Share by Players in 2024
Figure 18. Global NCI Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by NCI Digital Therapeutics Revenue in 2024
Figure 20. North America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 22. United States NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NCI Digital Therapeutics Market Share by Region (2020-2031)
Figure 34. China NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NCI Digital Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. MindMaze Labs Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 50. Akili Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 51. Cognoa Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 52. GrayMatters Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 54. TALi Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 55. Dario Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 56. Better Therapeutics Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 57. Nanjing Vishee Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 58. Zhejiang BrainAurora Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 59. Hunan Mental Health Medicine Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 60. Hunan Aize Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 61. Qingdao Zhisong Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232